Evidence map›Paper›PMID 39198190›Full record

ReviewEndocrine journal2024

A novel frameshift variant of GATA3 (p.Ala17ProfsTer178) responsible for HDR syndrome in a Japanese family.

Yutaka Hasegawa, Toshie Segawa, Ai Chida, Eriko Yoshida, Hirofumi Kinno, Hiraku Chiba, Tomoyasu Oda, Yoshihiko Takahashi, Koji Nata, Yasushi Ishigaki

Abstract readCase ReportsReview
In one paragraph

Review in Endocrine journal, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Yutaka HasegawaDivision of Diabetes, Metabolism and Endocrinology, Department of Internal Medicine, Iwate Medical University, Iwate 028-3695, Japan.ORCID http://orcid.org/0000-0003-0607-5452
Toshie SegawaDivision of Diabetes, Metabolism and Endocrinology, Department of Internal Medicine, Iwate Medical University, Iwate 028-3695, Japan.
Ai ChidaDivision of Diabetes, Metabolism and Endocrinology, Department of Internal Medicine, Iwate Medical University, Iwate 028-3695, Japan.
Eriko YoshidaDivision of Diabetes, Metabolism and Endocrinology, Department of Internal Medicine, Iwate Medical University, Iwate 028-3695, Japan.
Hirofumi KinnoDivision of Diabetes, Metabolism and Endocrinology, Department of Internal Medicine, Iwate Medical University, Iwate 028-3695, Japan.
Hiraku ChibaDivision of Diabetes, Metabolism and Endocrinology, Department of Internal Medicine, Iwate Medical University, Iwate 028-3695, Japan.
Tomoyasu OdaDivision of Diabetes, Metabolism and Endocrinology, Department of Internal Medicine, Iwate Medical University, Iwate 028-3695, Japan.
Yoshihiko TakahashiDivision of Diabetes, Metabolism and Endocrinology, Department of Internal Medicine, Iwate Medical University, Iwate 028-3695, Japan.
Koji NataDivision of Medical Biochemistry, School of Pharmacy, Iwate Medical University, Iwate 028-3694, Japan.
Yasushi IshigakiDivision of Diabetes, Metabolism and Endocrinology, Department of Internal Medicine, Iwate Medical University, Iwate 028-3695, Japan.ORCID http://orcid.org/0000-0003-2479-5752

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

HDR syndrome is an autosomal dominant disorder characterized by hypoparathyroidism (H), deafness (D), and renal dysplasia (R) caused by genetic variants of the GATA3 gene. We present the case of a 38-year-old Japanese man with HDR syndrome who exhibited hypoparathyroidism, sensorineural deafness, renal dysfunction, severe symptomatic hypocalcemia with Chvostek's and Trousseau's signs, and QT prolongation on electrocardiography. He had a family history of deafness and hypocalcemia. Genetic testing revealed a novel GATA3 gene variant at exon 2 (c.48delC), which induces a frameshift resulting in termination at codon 178, causing HDR syndrome. We summarized 45 Japanese cases of HDR syndrome with regard to the mode of onset (familial or sporadic) and the age at diagnosis. In addition, we summarized all previous cases of HDR syndrome with GATA3 gene variants. Mapping of previously reported genetic variants in HDR syndrome revealed that most missense variants were observed at exons 4 and 5 regions in the GATA3 gene. These two regions contain zinc finger domains, demonstrating their functional importance in GATA3 transcription. This review of literature provides a useful reference for diagnosing HDR syndrome and predicting the related future manifestations.

Indexed as

Frameshift MutationGATA3 Transcription FactorHearing Loss, SensorineuralHypoparathyroidismAdultEast Asian PeopleHumansJapanMaleNephrosisPedigreeGATA3 protein, humanGATA3 Transcription Factordeafness and renal dysplasia (HDR) syndromeGATA3Hypoparathyroidism

Identifiers

PMID39198190
PMCPMC11778358

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.